Recent studies have highlighted that the concentration of CXCL10 negatively correlates with the width of the CD4 + and CD8 + T cell repertoire in patients with acute COVID-19 (Rydyznski Moderbacher 2020). This evidence concerns the gene CD8A and COVID-19.